Illumina vs Intuitive Surgical

Illumina and Intuitive Surgical are two prominent companies in the healthcare industry, each specializing in innovative technologies that have revolutionized their respective fields. Illumina is at the forefront of genomics, providing cutting-edge sequencing technology for genetic research and diagnostic purposes. On the other hand, Intuitive Surgical is known for its da Vinci Surgical System, a state-of-the-art robotic platform used in minimally invasive surgeries. Both companies have seen impressive growth in recent years, making them attractive options for investors seeking exposure to the rapidly evolving healthcare sector.

Illumina or Intuitive Surgical?

When comparing Illumina and Intuitive Surgical, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Illumina and Intuitive Surgical.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Illumina has a dividend yield of -%, while Intuitive Surgical has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Illumina reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Intuitive Surgical reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Illumina P/E ratio at -7.71 and Intuitive Surgical's P/E ratio at 81.13. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Illumina P/B ratio is 16.34 while Intuitive Surgical's P/B ratio is 11.55.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Illumina has seen a 5-year revenue growth of 0.26%, while Intuitive Surgical's is 0.86%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Illumina's ROE at -64.72% and Intuitive Surgical's ROE at 15.36%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $145.58 for Illumina and $476.68 for Intuitive Surgical. Over the past year, Illumina's prices ranged from $86.58 to $151.37, with a yearly change of 74.84%. Intuitive Surgical's prices fluctuated between $254.85 and $496.48, with a yearly change of 94.81%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.